Leap Motion Controller on the Functionality of Upper Limbs in Parkinson's Disease
Leap Motion Controller on the Functionality of Upper Limbs in Parkinson's Disease
Is treatment with the Leap Motion Controller device effective for upper limb functionality in
 individuals with Parkinson's Disease?

 The present study presents two hypotheses:

 True hypothesis: There is an improvement in the functionality of MMSS after intervention with
 virtual reality? Null hypothesis: There is no improvement in the functionality of MMSS after
 intervention with virtual reality? The proposed work will be characterized as a Randomized
 Clinical Trial, with evaluators outside the experimental groups (single-blind). The sample
 will be probabilistic, from individuals diagnosed with Parkinson's disease.
STUDY METHODOLOGY

 1. RESEARCH DESIGN: The proposed work will be characterized as a Randomized Clinical Trial,
 with evaluators outside the experimental groups (single-blind). The sample will be
 probabilistic, from individuals diagnosed with Parkinson's disease.

 2. TYPE OF STUDY: Randomized Clinical Trial.

 3. AREA OF SCOPE: Major area: Health Sciences. Area: Physiotherapy and Occupational
 Therapy.

 4. LOCATION: The place where the entire study will be carried out will be in the home
 environment of each research participant.

 5. PARTICIPANTS: Participants will be recruited from an existing pre-existing list of
 research conducted on individuals with Parkinson's Disease from the UFCSPA. Individuals
 who: - are diagnosed with Parkinson's disease; - Classified as I-III on the Hoehn & Yahr
 motor staging scale; - Are over 18 years old (above this, without age restriction). -
 Residents in the city of Porto Alegre / RS. - Have signed the informed consent form
 (Appendix A). Individuals who: - Do not show the understanding of the games on the first
 day of familiarization; - Have a cerebral pacemaker implant; - Have recent injuries or
 limitations that make the MMSS impossible. - Do not perform / abstain from two
 appointments out of the 16 proposed in the intervention protocol, regardless of the
 group that will be allocated. The study will consist of two groups: intervention group
 (IG), which will receive treatment with Leap Motion Controller; and the control group
 (CG), who will receive treatment with conventional physiotherapy.

 6. EVALUATION INSTRUMENTS: A participant identification form will be filled out, containing
 full name, date of birth, gender, address, telephone number, education, diagnosis, time
 of diagnosis, onset of symptoms (laterality), associated diseases, PD subtype and
 medicines. Individuals will be assessed for: the motor aspects of experiences and
 activities of daily living using the TEMPA test and the Unified Assessment Scale for
 Parkinson's Disease (MDS-UPDRS) part II; Motor Assessment and subtype of the disease,
 using the MDS-UPDRS scale III; motor staging of PD using the Hoehn & Yahr scale; muscle
 strength and endurance, using the handgrip dynamometer (TEMPA test); manual dexterity,
 through the Box and Block test and the Nine Hole Peg test; cognitive issues through the
 Montreal Cognitive Assessment (MoCA); and quality of life, through the Questionnaire on
 Parkinson's Disease (PDQ-39).

 7. EXPECTED DURATION: The present research project contemplates different objectives, this
 being a study proposal to be developed during four years.

 8. PROCEDURES: The formation of each of the groups will be done through the generation of a
 random sequence through the tool available at http://www.randomize.com. Therefore,
 individuals will be divided into two groups: Intervention Group and Control Group.
 Subsequently, the initial assessment will be made,TEMPA, MDS-UPDRS-II e III, motor
 staging of the disease (H&Y), Box and Block Test, Nine Hole Peg Test), MoCA and
 PDQ-39.The IG will carry out a 2-month intervention protocol, with 16 40-minute
 interventions, twice a week. The CG will perform a conventional physiotherapy protocol
 for the same period as the IG. Therefore, all groups will receive the same evaluation
 procedures that will be performed before the intervention (PRE), after the intervention
 (POST) and, finally, 30 days after the intervention (follow-up). The researchers
 responsible for the intervention will not be aware of the evaluations carried out and
 the evaluators will not be aware of the group to which the participant will belong. Both
 groups will be able to follow their routine activities (physical and / or physical
 therapy) and all procedures will be performed in the home environment of each research
 participant.

 9. ETHICAL AND LEGAL PROCEDURES The study project in question will be submitted to the
 Research Ethics Committee of the Federal University of Health Sciences of Porto Alegre
 (UFCSPA) and will only be applied after due approval. All participants will be informed
 about the procedures, objectives, justifications, potential risks and benefits of their
 participation in the study. The research will not present risks to the participant, but
 if there is any discomfort during any activity, the treatment will be stopped
 immediately and the necessary measures taken. In addition, all participants must sign
 the informed consent form and receive a copy of it. The use of any type of image will
 not identify the participant and will only be used with written consent. The data in the
 medical record (name, telephone and address) will be used for screening in the
 identification and contact of individuals and stored in a database that will be accessed
 only by researchers.
Inclusion Criteria:

 -  Parkinson's disease diagnostic;

 -  Classified as I-III on the Hoehn & Yahr motor staging scale;

 -  Are over 18 years old (above this, without age restriction).

 -  Residents in the city of Porto Alegre / RS.

 -  Have signed an informed consent form.

 Exclusion Criteria:

 -  Do not show the understanding of the games on the first day of familiarization;

 -  Have a cerebral pacemaker implant;

 -  Have recent injuries or limitations that make the MMSS impossible.

 -  Do not perform / abstain from two appointments out of the 16 proposed in the
 intervention protocol, regardless of the group that will be allocated.